Cutaneous T-cell lymphoma, relapsed

Clinical trials for Cutaneous T-cell lymphoma, relapsed explained in plain language.

Never miss a new study

Get alerted when new Cutaneous T-cell lymphoma, relapsed trials appear

Sign up with your email to follow new studies for Cutaneous T-cell lymphoma, relapsed, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug cocktail aims to tackle tough skin cancer

Disease control Not yet recruiting

This study tests a combination of four chemotherapy drugs (aclarubicin, cyclophosphamide, vincristine, and prednisone) in people with cutaneous T-cell lymphoma that has come back or not responded to prior treatment. The trial has two phases: first, finding the safest dose of acla…

Matched conditions: CUTANEOUS T-CELL LYMPHOMA, RELAPSED

Phase 1/2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

Cutaneous T-cell lymphoma, relapsed

Get alerted when new Cutaneous T-cell lymphoma, relapsed trials appear

New drug cocktail aims to tackle tough skin cancer